• An infant with chronic severe neutropenia
• Antibiotics Associated With Clostridium difficile Infection
• Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
• Chronic neutropenia in adults
• ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry
• Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study
• Evans Syndrome
• HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR)
• Immediate Hypersensitivity Reactions
• Increased frequency of the single nucleotide polymorphism of the DARC/ACKR1 gene associated with ethnic neutropenia in a cohort of European patients with chronic idiopathic neutropenia
• Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital
• Iron overload induced by diphenylamine triggers reactive oxygen species and apoptosis in the spleen of pregnant rats and their fetuses
• Long-term outcomes with rituximab as add-on therapy in severe childhood-onset lupus nephritis
• Mesenchymal stem cells in immune-mediated bone marrow failure syndromes
• Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor
• Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry
• Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor
• Platelet count and dose, but not comorbidities, predict severe neutropenia in cabazitaxel-treated prostate cancer patients: A retrospective observational study
• PREDICTIVE VALUE OF SOLUBLE PROGRAMMED CELL DEATH LIGAND-1 IN THE PROGRESSION OF SEPTIC PATIENTS TO CHRONIC CRITICAL ILLNESS IN THE INTENSIVE CARE UNIT: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY
• Quality of life and patient-reported outcomes in chronic severe neutropenia conditions
• Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE-related neutropenia: a French Severe Chronic Neutropenia Registry study
• Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry
• Rhinocerebral Mucormycosis
• Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
• Severe chronic primary neutropenia in adults: report on a series of 108 patients
• Severe chronic primary neutropenia: findings from a patient who underwent exstensive evaluation including adenosine deaminase 2 gene variant assessment
• Shwachman-Diamond syndrome and solid tumors: Three new patients from the French Registry for Severe Chronic Neutropenia and literature review
• Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule
• The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
• The paradox of autoimmunity and autoinflammation in inherited neutrophil disorders - in search of common patterns
• The promise of novel treatments for severe chronic neutropenia
• The Therapeutic Potential of Angeli's Salt in Mitigating Acute <em>Trypanosoma cruzi</em> Infection in Mice
• Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia